General Atlantic
General Atlantic reported 12 stocks worth $2.5B in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are DLO (20.4%), CHYM (20.3%) and LFTO (16.1%). Compared with Q2 2026, the fund opened new positions in KRSA, added to RSKD, trimmed DLO, CHYM and XP and sold out of RVMD.
Latest filing: what General Atlantic did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() DLO Dlocal Ltd Class A Com | $507M | 20.4% | 36.8M | −9.8M (−21%) | 8 of 8 | |
| 2 | ![]() CHYM Chime Finl Inc | $504M | 20.3% | 18.9M | −2.3M (−11%) | 6 of 8 | |
| 3 | ![]() LFTO Liftoff Mobile Inc Com | $400M | 16.1% | 25.3M | No change | 2 of 8 | |
| 4 | ![]() XP XP Inc | $377M | 15.2% | 18M | −2.6M (−13%) | 8 of 8 | |
| 5 | ![]() ALKT Alkami Technology Inc | $265M | 10.7% | 19.4M | No change | 8 of 8 | |
| 6 | ![]() SPTX Seaport Therapeutics Inc | $123M | 5.0% | 6.1M | No change | 2 of 8 | |
| 7 | ![]() RSKD Riskified Ltd | $84.2M | 3.4% | 10.6M | +5.3M (+100%) | 8 of 8 | |
| 8 | ![]() NRIX Nurix Therapeutics Inc | $71.9M | 2.9% | 3M | No change | 4 of 8 | |
| 9 | ![]() PHVS Pharvaris N V | $52.4M | 2.1% | 1.7M | −4.9M (−75%) | 8 of 8 | |
| 10 | ![]() PBLS Parabilis Medicines Inc Com | $49.7M | 2.0% | 1.5M | No change | 2 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() RVMD Revolution Medicines Inc | $67M | 358K |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 13, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →General Atlantic 13F FAQ
What does General Atlantic own?
General Atlantic reported 12 stocks worth $2.5B in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are DLO (20.4%), CHYM (20.3%) and LFTO (16.1%). The table above lists every position in the filing (the top 10 without an account).
What did General Atlantic buy and sell in Q3 2026?
Compared with Q2 2026: 1 new positions, 1 added to, 4 trimmed and 1 sold out. New positions include KRSA. It sold all of RVMD.
When will General Atlantic file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is General Atlantic's portfolio worth?
The Q3 2026 filing reports $2.5B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.











